The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
|Poll|May 22, 2014
Hot Swollen Foot in a Man With Diabetes: Image IQ
Acute stage Charcot foot is seen in a 55-year-old man with type 2 diabetes mellitus. He has a history of peripheral neuroarthropathy with a 1-week history of a hot, swollen right foot. A radiograph of the foot revealed acute stage Charcot neuroarthropathy.
Advertisement
Acute stage Charcot foot is seen in a 55-year-old man with type 2 diabetes mellitus. He has a history of peripheral neuroarthropathy with a 1-week history of a hot, swollen right foot. A radiograph of the foot revealed acute stage Charcot neuroarthropathy.
Which of the following statements about Charcot foot is/are true?
Advertisement
Related to this article
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
2
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
5